THE VANDERBILT INSTITUTE FOR CLINICAL AND TRANSLATIONAL RESEARCH (VICTR): (BPCA)

$471,716UL1FY2009RRNIH

Vanderbilt University, Nashville TN

Investigators

Linked publications, trials & patents

Paper 39684829 Paper 39629588 Paper 39591102 Paper 39554078 Paper 39507410 Paper 39484575 Paper 39483920 Paper 39483879 Paper 39423129 Paper 39386686 Paper 39334471 Paper 39310214 Paper 39281711 Paper 39276127 Paper 39268356 Paper 39268202 Paper 39264172 Paper 39257990 Paper 39251213 Paper 39219981 Paper 39219855 Paper 39209900 Paper 39167600 Paper 39148751 Paper 39132494 Paper 39087502 Paper 39080328 Paper 39073750 Paper 39069519 Paper 39018351 Paper 39006447 Paper 38993526 Paper 38979162 Paper 38978579 Paper 38947092 Paper 38915549 Paper 38904429 Paper 38867043 Paper 38820087 Paper 38812968 Paper 38770789 Paper 38742219 Paper 38731867 Paper 38712091 Paper 38699370 Paper 38686878 Paper 38682900 Paper 38649760 Paper 38645405 Paper 38645082 Paper 38644690 Paper 38632388 Paper 38621411 Paper 38614075 Paper 38604128 Paper 38585743 Paper 38571954 Paper 38542239 Paper 38534508 Paper 38531883 Paper 38530135 Paper 38526701 Paper 38501205 Paper 38488511 Paper 38454796 Paper 38421866 Paper 38335901 Paper 38303157 Paper 38293237 Paper 38214447 Paper 38188934 Paper 38177345 Paper 38168206 Paper 38141840 Paper 38126226 Paper 38106099 Paper 38085509 Paper 38078748 Paper 38014176 Paper 38001111 Paper 37986975 Paper 37986756 Paper 37986731 Paper 37961557 Paper 37960952 Paper 37953184 Paper 37942584 Paper 37938976 Paper 37935199 Paper 37921055 Trial NCT02203630 Trial NCT01600586 Trial NCT00954564 Trial NCT00838695 Trial NCT00837902 Trial NCT00685945 Trial NCT00581633 Trial NCT00581321 Trial NCT00581022 Patent 9795640

Abstract

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This supplemental award provides funds to CTSA Consortium-supported research projects for research on outcome measures in clinical and translational child health in priority areas as determined by the Best Pharmaceuticals for Children Act (BPCA) program administered by NICHD.

View original record on NIH RePORTER →